The end date for this most recent search update for our living systematic review ([@r1-L200944]) is 7 June 2020. We found 6 new citations that met eligibility for inclusion in our review addressing noninvasive mechanical ventilation for individuals with acute hypoxic respiratory failure caused by coronavirus (coronavirus disease 2019 \[COVID-19\], Middle East respiratory syndrome, and severe acute respiratory syndrome) ([@r2-L200944]). Five are cohort studies ([@r2-L200944], [@r4-L200944], [@r5-L200944]) and one is a randomized controlled trial (RCT) ([@r4-L200944]) ([Supplement Tables 1 and 2](#s1-L200944){ref-type="supplementary-material"}). The RCT, which had some concerns regarding risk of bias, compared high-flow nasal cannula (HFNC) with standard oxygen therapy in 74 patients with COVID-19 ([@r4-L200944]). Use of HFNC was associated with a reduction in the need for invasive mechanical ventilation and improvements in oxygenation compared with standard oxygen therapy. Of the 5 cohort studies, 1 compared HFNC with invasive mechanical ventilation ([@r3-L200944]), 1 compared bilevel noninvasive ventilation with standard oxygen therapy ([@r7-L200944]), 1 compared bilevel noninvasive ventilation with both invasive mechanical ventilation and standard oxygen therapy ([@r6-L200944]), 1 compared bilevel noninvasive ventilation with HFNC ([@r5-L200944]), and 1 compared bilevel noninvasive ventilation with invasive mechanical ventilation ([@r2-L200944]). All of the cohort studies had moderate risk of bias with Ottawa--Newcastle scores of 6 to 7. Two of them included fewer than 10 patients with such a low number of events that trustworthy conclusions were not possible ([@r3-L200944], [@r5-L200944]). The other cohort studies did not report many of our outcomes of interest; when they did, there was no important difference between groups.

In summary, the most informative new study included in this update, an RCT done by Li and colleagues ([@r4-L200944]), demonstrated results consistent with our current understanding that the use of HFNC compared with standard oxygen therapy may decrease the need for invasive mechanical ventilation in patients with COVID-19.
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